Veru is trading 5.2% down at $2.29, giving back part of yesterday’s bounce as the stock tracks a broader market decline.
- There are no fresh company-specific headlines, filings, or analyst actions reported for July 16, 2026, to explain the move.
- The decline appears driven by risk-off sentiment, with both biotech stocks and major U.S. indices trading lower.
- Shares have recently experienced significant volatility, fluctuating within a range of $2.30 to $2.80.